Bilaketaren emaitzak - John A. Kessler

Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor nork John A. Kessler, Aziz Shaibani, Christine N. Sang, Mark Christiansen, David Kudrow, Aaron Vinik, Nari Shin, the VM202 study group

Connect to this object online.